Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Neus Basté Rotllán"'
Autor:
Neus Basté Rotllan
Publikováno v:
Cancer Medicine, Vol 11, Iss S1, Pp 10-16 (2022)
Abstract In this article, we focus on a variety of immunosuppression scenarios and whether multikinase inhibitors, as systemic therapy for advanced thyroid carcinoma (TC), could be useful for the treatment of immunocompromised patients with TC. Lenva
Externí odkaz:
https://doaj.org/article/0ff17f65ebda41939668d84e6faf1ec0
Autor:
Julio Jose Lambea Sorrosal, Gema Bruixola, Javier Martinez-Trufero, Beatriz Cirauqui, Almudena García Castaño, Javier Caballero Daroqui, Jordi Rubió-Casadevall, Ricard Mesia, Pedro Perez, Alberto Carral, Vanesa Gutierrez Calderon, Edel del Barco, Joaquina Martínez-Galán, Marc Oliva Bernal, Laura Basterretxea, Virginia Arrazubi, Lara Iglesias, Ruth Alvarez, Ana Medina, Neus Basté Rotllán, Neck Cancer Treatment
Publikováno v:
Journal of Clinical Oncology. 39:TPS6086-TPS6086
TPS6086 Background: Nivolumab is the standard of care for patients (pts) with R/M HNSCC in the platinum-refractory setting. Up to 20% of R/M HNSCC pts are ineligible for cisplatin-based CT due to poor performance status and/or comorbidities. ERBITAX
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2c9753b15279c7a6fd5a67649355aa3
https://doi.org/10.1200/jco.2021.39.15_suppl.tps6086
https://doi.org/10.1200/jco.2021.39.15_suppl.tps6086